The Scientist

» pharmaceuticals and ecology

Most Recent

image: Drugmaker Teva Bids $40 Billion for Mylan

Drugmaker Teva Bids $40 Billion for Mylan

By | April 23, 2015

The Israel-based pharmaceutical company makes an unsolicited offer for a smaller, Netherlands-based rival as its main product faces competition from generics.


image: AbbVie Wins Bidding War for Cancer Drugmaker

AbbVie Wins Bidding War for Cancer Drugmaker

By | March 5, 2015

The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.


image: Capsule Reviews

Capsule Reviews

By | March 1, 2015

Evolving Ourselves, The Man Who Touched His Own Heart, Bats, and The Invaders

1 Comment

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.


image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Taming Bushmeat

Taming Bushmeat

By | January 1, 2015

Chinese farmers’ efforts at rearing wild animals may benefit conservation and reduce human health risks.

1 Comment

image: Bats Make a Comeback

Bats Make a Comeback

By | December 22, 2014

Citizen-scientist data obtained through the U.K.’s National Bat Monitoring Programme show that populations of 10 bat species have stabilized or are growing.


image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.


image: Pharma and Biotech Firms Hacked

Pharma and Biotech Firms Hacked

By | December 2, 2014

Cyberspies have broken into the e-mails of a number of publicly traded companies, most of which are in health care and pharmaceuticals.


image: Along Came a Spider

Along Came a Spider

By | December 1, 2014

Researchers are turning to venom peptides to protect crops from their most devastating pests.


Popular Now

  1. HIV Spread from Haiti to NYC in 1970, “Patient Zero” Not to Blame
  2. Culprit for Antibody Blockade Identified
  3. Investigation Finds Pathologist Guilty of Systemic Misconduct
  4. Many Evolutionary Paths Lead to Same Bird Trait